biontech news - Search News

Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal.

National Post · 3d

Updated Pfizer-BioNTech’s COVID-19 vaccine approved by Health Canada

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.

Business Insider · 7d

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and

MarketWatch · 3d

Pfizer/BioNTech Covid-19 Vaccine Adapted for KP.2 Strain Gets Canada Approval

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top

cbc.ca on MSN · 3d

Pfizer's updated COVID-19 vaccine approved, Health Canada says

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada said on Tuesday.

The Canadian Press on MSN · 3d

Health Canada approves Pfizer's updated COVID-19 vaccine, manufacturer says

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.

MarketWatch · 3d

Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine

Omicron KP.2 variant adapted vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks. -- The updated COVID-19 vaccine is tailored to the KP.

MarketWatch12h

BioNTech SE ADR rises Friday, outperforms market

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

15hon MSN

Medical Breakthrough: 1st lung cancer vaccine BNT116 clinical trials launched, vaccine based on Covid mRNA

BioNTech has launched global clinical trials for BNT116, an mRNA vaccine designed to treat non-small cell lung cancer.

8don MSN

BioNTech Is More Than a Covid-19 Stock. It’s Having a Great September.

BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...

14d

Forecasting The Future: 8 Analyst Projections For BioNTech

BioNTech BNTX has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from ...

Pharmaceutical Technology4d

BioNTech gets grant for rna lipoplex particles for targeted delivery and storage

Discover BioNTech SE's innovative RNA lipoplex patent, detailing advanced methods for stable RNA delivery, GMP production, and effective intravenous administration.

17d

Promising BNT327 Data Bolsters BioNTech’s Buy Rating, With a Target of $171

Analyst John Newman of Canaccord Genuity maintained a Buy rating on BioNTech SE (BNTX – Research Report), retaining the price target of ...

Finanznachrichten10d

BioNTech Stock: Oncology Pipeline Fuels Market Resurgence

BioNTech's shares have experienced a remarkable upswing, with the stock price soaring to $130.90 on NASDAQ, marking a 6.0% increase in the latest session. This surge represents a significant ...